Publicacions en col·laboració amb investigadors/es de Hospital de Gran Canaria Dr. Negrin (12)

2024

  1. Effectiveness and safety of levodopa–entacapone–carbidopa infusion in Parkinson disease: A real-world data study

    European Journal of Neurology

2023

  1. Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children

    Science (New York, N.Y.), Vol. 379, Núm. 6632, pp. eabo3627

  2. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

2022

  1. Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience

    Cancers, Vol. 14, Núm. 7

2021

  1. SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease?

    Journal of Experimental Medicine, Vol. 218, Núm. 6

2020

  1. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  2. Executive summary: Consensus document of the diagnosis, management and prevention of infection with the hepatitis E virus: Study Group for Viral Hepatitis (GEHEP) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 1, pp. 28-32

  3. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  4. Pretreatment inflammatory indices predict Bevacizumab response in recurrent Glioma

    Cancer Drug Resistance, Vol. 3, Núm. 3, pp. 623-635

2019

  1. Correction to: Morphological MRI-based features provide pretreatment survival prediction in glioblastoma (European Radiology, (2019), 29, 4, (1968-1977), 10.1007/s00330-018-5758-7)

    European Radiology

  2. Morphological MRI-based features provide pretreatment survival prediction in glioblastoma

    European Radiology, Vol. 29, Núm. 4, pp. 1968-1977

2012

  1. Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: The ANIMO study

    Movement Disorders, Vol. 27, Núm. 2, pp. 211-218